7Berger J, Moller DE. The mechanisms of action of PPARs[J]. Annu Rev Med,2002,339: 953--959.
8Friedewald TT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge[J]. Clin Chem,1972,18: 499--502.
9Guan Y, Breyer MD. Targeting peroxisome proliferators-activated-receptors (PPARs) in kidney and urologic disease[J]. Minerva Urol Nefrol, 2002,54:65--79.
10Wang XL, Oosterhof J, Natalia D. Peroxisome proliferators-activated-receptor γ C161→T polymorphism and coronary artery disease[J]. Cardiovascul Res, 1999, 44: 588--594.
